Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. Panova, E. Ovsyankina, D. Guiller, M. Gubkina, M. Kobulashvili (Moscow, Russian Federation). Effectiveness of treatment for MDR TB in children and adolescents. Eur Respir J 2007; 30: Suppl. 51, 4119

Member's Comments

No comment yet.

Related content which might interest you: Preventive chemotherapy effectiveness in children and adolescents, contacting TB patients with DR TB strains Source: Eur Respir J 2006; 28: Suppl. 50, 536s Year: 2006 The effectiveness of MDR TB treatment in children and adolescents depending on its duration Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012 Challenges in TB treatment in children Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 Risk factors for multi-drug resistant TB in children and adolescents Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007 New approaches to MDR/XDR TB chemotherapy in children and adolescents Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019 Challenges in TB treatment in adults Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 The comparative analysis of treatment effectiveness in children and adolescents with MDR TB with anti-TB drugs of the first and second lines Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012 The clinical features and treatment of cases with MDR TB of adolescents Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007 Identification and clinical management of LTBI in children versus adults Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 TB-incidence and role of preventive chemotherapy in children and adolescents from bacillary DR TB-pestholes Source: Eur Respir J 2007; 30: Suppl. 51, 413s Year: 2007 Compassionate use of delamanid in adults and children for drug-resistant tuberculosis: 5-year update Source: Eur Respir J, 57 (5) 2002483; 10.1183/13993003.02483-2020 Year: 2021 Multidrug-resistance tuberculosis and HIV-infected patients, the effectiveness of the treatment in Ukraine Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 New and repurposed TB drugs use in children and adolescents with M/XDR-TB Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now? Year: 2017 Outcomes of individualized treatment for MDR TB in Iran Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007 Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges Source: Eur Respir J 2016; 48: 938-943 Year: 2016 Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of multidrug-resistant tuberculosis Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 Surgical treatment for MDR TB patients – preliminary results from a Romanian MDR TB centre Source: Eur Respir J 2006; 28: Suppl. 50, 276s Year: 2006 Treatment outcomes among childhood extensively drug-resistant tuberculosis patients in Pakistan Source: ERJ Open Res, 8 (1) 00551-2021; 10.1183/23120541.00551-2021 Year: 2022